NCT04811183

Brief Summary

Investigators hypothesize that the implementation of a hospital pharmacy consultation and the transmission of its report to pharmacies may improve knowledge, adherence and encourage the development of pharmacist medication reviews. A before-and-after study of the implementation of pharmaceutical consultations will allow the investigators to evaluate the validity of the hypothesis.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 23, 2021

Completed
2.3 years until next milestone

Study Start

First participant enrolled

June 23, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2023

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

Same day

First QC Date

March 19, 2021

Last Update Submit

March 26, 2025

Conditions

Keywords

pharmaceutical consultationsadherence

Outcome Measures

Primary Outcomes (2)

  • Evolution in the knowledge about the patient's condition

    Treatment knowledge, knowledge about the pathology and knowledge of hygienic and dietary measures will be assessed with a questionnaire giving a score from 0 to 2 -the higher the score, the better the outcome-. Comparison of the knowledge of the treatment between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation. Statistical evaluation by comparative tests between the two questionnaires.

    One week

  • Evolution in the adherence

    Evaluation of the patient's adherence to his treatment through a questionnaire giving a score between 0 to 6 -the higher the score, the better the outcome-. Comparison of the scores between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation. Statistical evaluation by comparative tests between the two questionnaires.

    One week

Study Arms (1)

Experimental group

Adult patients hospitalized with diabetes and polymedicated. Selected to benefit from a pharmaceutical consultation before their return home.

Behavioral: Pharmaceutical consultation

Interventions

Selection of patients for a pharmaceutical consultation with collection of non-opposition and scheduling of telephone interviews or by teleconsultations at one week after hospitalization. Data collection through interviews using a telephone questionnaire (or by teleconsultation) one week after consultation. Elements on knowledge and adherence of treatment will be collected.

Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than 5 concomitting treatments, on the way to returning home.

You may qualify if:

  • Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than 5 concomitant treatments
  • Adult patient that is being discharged for a return home
  • Good comprehension of French

You may not qualify if:

  • Bad comprehension of French

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Louis Pradel

Bron, 69577, France

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2021

First Posted

March 23, 2021

Study Start

June 23, 2023

Primary Completion

June 23, 2023

Study Completion

June 23, 2023

Last Updated

April 1, 2025

Record last verified: 2025-03

Locations